- Home
- ENX vs BWAY Comparison
ENX vs BWAY Comparison
Compare ENX & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENX
- BWAY
- Stock Information
- Founded
- ENX 2002
- BWAY 2003
- Country
- ENX United States
- BWAY Israel
- Employees
- ENX N/A
- BWAY N/A
- Industry
- ENX Finance/Investors Services
- BWAY Medical/Dental Instruments
- Sector
- ENX Finance
- BWAY Health Care
- Exchange
- ENX Nasdaq
- BWAY Nasdaq
- Market Cap
- ENX 174.2M
- BWAY 207.4M
- IPO Year
- ENX N/A
- BWAY 2019
- Fundamental
- Price
- ENX $9.48
- BWAY $8.76
- Analyst Decision
- ENX
- BWAY Strong Buy
- Analyst Count
- ENX 0
- BWAY 3
- Target Price
- ENX N/A
- BWAY $13.17
- AVG Volume (30 Days)
- ENX 25.4K
- BWAY 24.0K
- Earning Date
- ENX 01-01-0001
- BWAY 05-13-2025
- Dividend Yield
- ENX 3.94%
- BWAY N/A
- EPS Growth
- ENX N/A
- BWAY N/A
- EPS
- ENX 0.16
- BWAY 0.06
- Revenue
- ENX N/A
- BWAY $41,016,000.00
- Revenue This Year
- ENX N/A
- BWAY $351.53
- Revenue Next Year
- ENX N/A
- BWAY $21.84
- P/E Ratio
- ENX $61.00
- BWAY $57.37
- Revenue Growth
- ENX N/A
- BWAY 29.04
- 52 Week Low
- ENX $7.84
- BWAY $5.13
- 52 Week High
- ENX $10.07
- BWAY $11.79
- Technical
- Relative Strength Index (RSI)
- ENX 55.13
- BWAY 47.80
- Support Level
- ENX $9.37
- BWAY $8.61
- Resistance Level
- ENX $9.53
- BWAY $9.09
- Average True Range (ATR)
- ENX 0.11
- BWAY 0.38
- MACD
- ENX 0.04
- BWAY 0.05
- Stochastic Oscillator
- ENX 83.38
- BWAY 58.73
About ENX Eaton Vance New York Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance New York Municipal Bond Fund is principally engaged in managing investment funds and providing investment management and advisory services to high-net-worth individuals and institutions. It is a non-diversified, closed-end investment company. Its objective is to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in specified state.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.